Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood tests during long-term treatment: cohort study using data from the Clinical Practice Research Datalink Gold and Aurum.
Nakafero G, Grainge MJ, Card T, Taal MW, Aithal GP, Zhang W, Doherty M, Fox CP, Mallen CD, Abhishek A. Nakafero G, et al. Among authors: abhishek a. Rheumatology (Oxford). 2022 Jul 6;61(7):2783-2791. doi: 10.1093/rheumatology/keab790. Rheumatology (Oxford). 2022. PMID: 34718430 Free PMC article.
Incidence and pattern of mycophenolate discontinuation associated with abnormal monitoring blood-test results: cohort study using data from the Clinical Practice Research Datalink Aurum.
Nakafero G, Grainge MJ, Card T, Mallen CD, Riley R, van der Windt D, Fox CP, Taal MW, Aithal GP, Williams HC, Abhishek A. Nakafero G, et al. Among authors: abhishek a. Rheumatol Adv Pract. 2022 Jun 2;6(2):rkac046. doi: 10.1093/rap/rkac046. eCollection 2022. Rheumatol Adv Pract. 2022. PMID: 35702565 Free PMC article.
Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK.
Nakafero G, Grainge MJ, Williams HC, Card T, Taal MW, Aithal GP, Fox CP, Mallen CD, van der Windt DA, Stevenson MD, Riley RD, Abhishek A. Nakafero G, et al. Among authors: abhishek a. BMJ. 2023 May 30;381:e074678. doi: 10.1136/bmj-2022-074678. BMJ. 2023. PMID: 37253479 Free PMC article.
Risk-stratified monitoring for thiopurine toxicity in immune-mediated inflammatory diseases: prognostic model development, validation, and, health economic evaluation.
Nakafero G, Card T, Grainge MJ, Williams HC, Taal MW, Aithal GP, Fox CP, Mallen CD, van der Windt DA, Stevenson MD, Riley RD, Abhishek A. Nakafero G, et al. Among authors: abhishek a. EClinicalMedicine. 2023 Sep 14;64:102213. doi: 10.1016/j.eclinm.2023.102213. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37745026 Free PMC article.
Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies.
Abhishek A, Stevenson MD, Nakafero G, Grainge MJ, Evans I, Alabas O, Card T, Taal MW, Aithal GP, Fox CP, Mallen CD, van der Windt DA, Riley RD, Warren RB, Williams HC. Abhishek A, et al. Br J Dermatol. 2024 Mar 15;190(4):559-564. doi: 10.1093/bjd/ljad430. Br J Dermatol. 2024. PMID: 37931161 Free article.
Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritis.
Jani M, Chinoy H, Warren RB, Griffiths CE, Plant D, Fu B, Morgan AW, Wilson AG, Isaacs JD, Hyrich K, Barton A; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate Collaborators. Jani M, et al. Arthritis Rheumatol. 2015 May;67(8):2011-9. doi: 10.1002/art.39169. Arthritis Rheumatol. 2015. PMID: 26109489 Free PMC article.
220 results